(secondQuint)A Ph2a, Open-Label, Multicenter, Activity&Safety Study of KX2-391 Oint in Subj.

 w Actinic Keratosis on the Face or Scalp.

 This study will be an open-label, multicenter, activity, safety, tolerability, and PK study of KX2-391 Ointment administered topically to the face or scalp of subjects with actinic keratosis.

 The study consists of Screening, Treatment, and Follow-up Periods.

 Eligible subjects will receive X consecutive days of topical treatment, to be applied at the study site.

 Blood samples for PK analysis will be collected.

 Activity (lesion counts) and safety evaluations will be performed.

.

 A Ph2a, Open-Label, Multicenter, Activity&Safety Study of KX2-391 Oint in Subj.

 w Actinic Keratosis on the Face or Scalp@highlight

In this study, the activity, safety, and pharmacokinetics (PK) of KX2-391 Ointment will be evaluated in adult subjects with a clinical diagnosis of stable, clinically typical actinic keratosis (AK) on the face or scalp.

